<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/oppfi-beats-dfpi-true-lender/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T09:19:37.000Z</news:publication_date>
      <news:title>Rejected: DFPI&apos;s True Lender Claim Against OppFi</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/gilead-tubulis-tub040-ovarian-adc/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-31T09:17:51.472Z</news:publication_date>
      <news:title>Gilead Paid $3.15B for Tubulis; TUB-040 Posts 61% ORR</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/kalshi-cftc-sue-minnesota-prediction-ban/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T22:34:19.000Z</news:publication_date>
      <news:title>Kalshi, CFTC Sue Minnesota Over Felony Prediction Ban</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/pets-cross-border-data-pilot/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T22:06:43.000Z</news:publication_date>
      <news:title>PETs Cut Cross-Border Approvals From 12 Months to 2</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/incyte-monjuvi-dlbcl-phase3/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T21:35:43.000Z</news:publication_date>
      <news:title>Cuts DLBCL Risk 25%: Monjuvi Takes On Polivy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/pfizer-talzenna-52pct-mcspc-pfs/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T21:06:57.000Z</news:publication_date>
      <news:title>Pfizer Cuts J&amp;J&apos;s mCSPC Lead With 52% PFS Win</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/summit-ivonescimab-harmoni6-asco-plenary/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T23:09:29.000Z</news:publication_date>
      <news:title>Summit&apos;s Ivonescimab OS Data Could Shake NSCLC Billions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/alchymars-fda-warning-repeat/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T22:32:21.000Z</news:publication_date>
      <news:title>FDA Warns Alchymars Again: Eight Years, Same Gaskets</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/greensky-10m-senior-lending-scheme/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T21:55:38.000Z</news:publication_date>
      <news:title>GreenSky Pays $10M in Senior Lending Scheme</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/bonta-sues-23andme-genetic-data-breach/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T21:12:38.000Z</news:publication_date>
      <news:title>Bonta Sues 23andMe Over 6.9M Genetic Data Breach</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/charter-shinyhunters-breach-49m/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T13:28:46.000Z</news:publication_date>
      <news:title>Paid No Ransom; ShinyHunters Leaked 4.9M Charter Accounts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/anthropic-65b-series-h-valuation/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T12:03:51.000Z</news:publication_date>
      <news:title>Raised $65B, Anthropic Tops OpenAI at $965B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/illinois-sb-315-frontier-ai-audit/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T10:49:58.000Z</news:publication_date>
      <news:title>SB 315 Makes Illinois Third State With AI Audit Law</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/pfizer-innovent-china-cancer-deal/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T09:28:32.000Z</news:publication_date>
      <news:title>Pfizer Buys 12-Drug China Cancer Portfolio for $650M</news:title>
    </news:news>
  </url>
</urlset>